This month, the Olon USA team will be on the ground in DCAT Week, meeting with partners and sponsors in Manhattan to discuss how the organization continues to evolve alongside a rapidly shifting pharmaceutical development landscape.

As in recent years, DCAT Week provides a focused, high-value environment for meaningful conversations—less about spectacle, more about substance. For Olon USA, that substance centers on execution, reliability, and long-term partnership across the full lifecycle of small-molecule development and manufacturing.

A Unified Global Presence

This year’s meetings will carry added significance, with representatives from Olon’s parent company, Olon SpA, joining the U.S. team in New York. Together, they will highlight the strategic advantage of Olon’s integrated global footprint—linking U.S.-based manufacturing and technical support with complementary European capabilities to provide clients with continuity, flexibility, and scale.

For sponsors navigating increasingly complex supply-chain decisions, this unified presence reinforces a simple message: Olon operates as one organization across regions, with shared standards, shared expertise, and shared accountability.

Continuing the Conversation from Recent Updates

Building on themes from Olon USA’s recent communications, the team is looking forward to deeper discussions around the investments and operational updates shaping the company’s near- and long-term direction. These include expanded U.S. manufacturing capabilities, ongoing infrastructure enhancements, and a continued focus on supporting programs as they advance from early development through commercial supply.

Clients can also expect conversations around how Olon’s technical depth—spanning process development, scale-up, and commercial manufacturing—supports predictable timelines and informed decision-making, even as market conditions and regulatory expectations continue to evolve.

Looking Ahead to 2026 and Beyond

DCAT Week is not just a checkpoint—it’s a planning moment. Olon USA and Olon SpA will be using their time in New York to engage with partners about what lies ahead: upcoming capacity, evolving sponsor needs, and how a globally aligned CDMO partner can reduce risk while enabling growth.

For organizations seeking a manufacturing partner that combines global reach with local execution, DCAT Week in New York offers an ideal setting to continue the conversation.

The Olon team looks forward to connecting in Manhattan and exploring what the next phase of collaboration can look like—together.